January’s new drug price increases take off without overcompensating for upcoming inflation-linked rebates
Pharma’s annual price increases on drugs — the vast majority of which usually occur in January of every year — didn’t noticeably spike this year (so far) when compared to recent years, and experts say it doesn’t seem like pharma is desperate yet to make up for what may be major losses in sales thanks to government negotiations for some high-earning drugs come 2026.
Analysts at 46Brooklyn published their latest 450+ available increases on list prices (not to be confused with the prices people pay out of pocket), as of Jan. 1, finding that as with previous years, most of the increases remained at or below the industry bar of 10%, and a median price increase of 5% so far in 2023.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters